The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target

The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by senile plaques formed by amyloid-beta (Aβ) extracellularly and neurofibrillary tangles (NFTs) formed by hyperphosphorylated tau protein intracellularly. Apart from these two features, insulin deficiency and insulin resistance...

Full description

Bibliographic Details
Main Authors:	Guanying You, Jinyi Yao, Qiong Liu, Nan Li
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Current Issues in Molecular Biology
Subjects:	Alzheimer’s disease insulin resistance amyloid-beta tau phosphorylation microglia
Online Access:	https://www.mdpi.com/1467-3045/44/12/421

Similar Items

Aberrant insulin signaling in Alzheimer’s disease: current knowledge
by: Gaurav eBedse, et al.
Published: (2015-06-01)

Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease
by: Dawling A. Dionisio-Santos, et al.
Published: (2021-10-01)

The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD
by: Jinyi Yao, et al.
Published: (2023-07-01)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
by: Zenghui Wei, et al.
Published: (2021-07-01)

Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
by: Ziyad M. Althafar
Published: (2022-06-01)

Effects of early tooth loss on chronic stress and progression of neuropathogenesis of Alzheimer’s disease in adult Alzheimer’s model AppNL-G-F mice
by: Suzuko Ochi, et al.
Published: (2024-02-01)

Identification of a dysfunctional microglial population in human Alzheimer’s disease cortex using novel single-cell histology image analysis
by: Molly E. V. Swanson, et al.
Published: (2020-10-01)

Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease
by: Toshitaka Ochiai, et al.
Published: (2021-11-01)

The Functions and Phenotypes of Microglia in Alzheimer’s Disease
by: Risako Fujikawa, et al.
Published: (2023-04-01)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
by: Priyanka Rawat, et al.
Published: (2022-10-01)

Oral Administration of Probiotic Bacteria Alleviates Tau Phosphorylation, Aβ Accumulation, Microglia Activation, and Memory Loss in 5xFAD Mice
by: Yeong Jin Kim, et al.
Published: (2024-02-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-02-01)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
by: P. Hemachandra Reddy, et al.
Published: (2019-05-01)

Alzheimer’s disease and anesthesia
by: Marie-Amélie ePapon, et al.
Published: (2011-01-01)

Photo-Oxygenation as a New Therapeutic Strategy for Neurodegenerative Proteinopathies by Enhancing the Clearance of Amyloid Proteins
by: Ikumi Tomizawa, et al.
Published: (2022-06-01)

Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
by: Kevin A. Clayton, et al.
Published: (2017-12-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
by: Jean-Marie eSontag, et al.
Published: (2014-03-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
by: Yuanxin Zhao, et al.
Published: (2022-07-01)

Proposed mechanisms of tau: relationships to traumatic brain injury, Alzheimer’s disease, and epilepsy
by: Samantha P. Martin, et al.
Published: (2024-01-01)

The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease
by: Haiyang Du, et al.
Published: (2022-11-01)

Frontal lobe microglia, neurodegenerative protein accumulation, and cognitive function in people with HIV
by: Jacinta Murray, et al.
Published: (2022-05-01)

Amyloid-β Oligomers Unveil a Novel Primate Model of Sporadic Alzheimer’s Disease
by: Joseph eJebelli, et al.
Published: (2015-03-01)

Iron Deposition Leads to Hyperphosphorylation of Tau and Disruption of Insulin Signaling
by: Wenbin Wan, et al.
Published: (2019-06-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-06-01)

Salivary levels of disease-related biomarkers in the early stages of Parkinson’s and Alzheimer’s disease: A cross-sectional study
by: Masoomeh Sabaei, et al.
Published: (2023-06-01)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
by: Guimei Zhang, et al.
Published: (2021-11-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
by: Helena Colvee-Martin, et al.
Published: (2024-03-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
by: Caterina Motta, et al.
Published: (2023-08-01)

Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
by: Nasim Rezaee, et al.
Published: (2021-10-01)

The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer’s disease: a longitudinal PET study
by: Rola Ismail, et al.
Published: (2020-05-01)

Effects of Specific Inhibitors for CaMK1D on a Primary Neuron Model for Alzheimer’s Disease
by: Paige Grant, et al.
Published: (2021-12-01)

Dietary glucosinolates derived isothiocyanates: chemical properties, metabolism and their potential in prevention of Alzheimer’s disease
by: Farhana Khan, et al.
Published: (2023-07-01)

The identities of insulin signaling pathway are affected by overexpression of Tau and its phosphorylation form
by: Ningtian Ma, et al.
Published: (2022-12-01)

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
by: Raquel Sanchez-Varo, et al.
Published: (2022-05-01)

Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis
by: Zsolt Huszár, et al.
Published: (2024-04-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)